Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in TG THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 235,477 shares of TGTX (TG THERAPEUTICS INC), worth $7.8M as of 2026-Q1. The position was decreased (-1.3% shares). TGTX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$7.8M
Current Shares
235,477
Total Value Change
+$2.1M
Total Shares Change
-86,397
Other major holders of TGTX: BNP PARIBAS FINANCIAL MARKETS
Decreased |
| 235,477 |
-1.3% |
| $7.8M |
| 0.0% |
| $28.88 |
0 |
| 2025-Q4 | Decreased | 238,686 | -2.6% | $7.1M | 0.0% | $29.75 | 0 |
| 2025-Q3 | Decreased | 245,051 | -40.1% | $8.9M | 0.0% | $36.83 | 0 |
| 2025-Q2 | Increased | 409,393 | +42.6% | $14.7M | 0.0% | $36.72 | 38 |
| 2025-Q1 | Increased | 287,059 | +5.4% | $11.3M | 0.0% | $39.86 | 29 |
| 2024-Q4 | Decreased | 272,370 | -7.3% | $8.2M | 0.0% | $31.44 | 0 |
| 2024-Q3 | Decreased | 293,927 | -8.7% | $6.9M | 0.0% | $23.83 | 0 |
| 2024-Q2 | Increased | 321,874 | +98.8% | $5.7M | 0.0% | $17.79 | 44 |